• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Clinoril (sulindac) tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – June 2010

Summary View


Drug Interactions
  • ACE-Inhibitors and Angiotensin II Antagonists:  Therefore, the combination should be administered with caution in patients with compromised renal function.